City

Seattle (1)

Condition

B Acute Lymphoblastic Leukemia (1)

B Lymphoblastic Lymphoma (1)

Recurrent Adult Acute Lymphoblastic Leukemia (1)

Recurrent B Lymphoblastic Lymphoma (1)

Recurrent T Lymphoblastic Leukemia/Lymphoma (1)

Refractory B Lymphoblastic Lymphoma (1)

Refractory T Lymphoblastic Lymphoma (1)

T Acute Lymphoblastic Leukemia (1)

T Lymphoblastic Lymphoma (1)

Overall Status

Withdrawn (1)

Phase

phase 2 (1)

Sponsor

University of Washington (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

asparaginase (1)

cyclophosphamide (1)

doxorubicin hydrochloride (1)

etoposide (1)

imatinib mesylate (1)

laboratory biomarker analysis (1)

prednisone (1)

rituximab (1)

vincristine sulfate (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

Other (1)

Study Type

Interventional (1)

refractory t lymphoblastic lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Recurrent Adult Acute Lymphoblastic Leukemia Trial in Seattle (drug,

Withdrawn

B Acute Lymphoblastic Leukemia
+8 more

Asparaginase
+8 more

Seattle, Washington

Fred Hutchinson Cancer Research Center/University of Washington

Nov 9, 2018